Gülay Sain Güven
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gülay Sain Güven has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Oğuz Abdullah Uyaroğlu
Hacettepe University Faculty of Medicine
14 shared publications - Nursel Çalık Başaran
Hacettepe Universitesi Tip Fakultesi
12 shared publications - Lale Ozisik
Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye
11 shared publications - Mine Durusu Tanriover
Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye
6 shared publications - Murat Özdede
Department of Internal Medicine, Hacettepe University Faculty of Medicine , Ankara
5 shared publications - Ahmet Cagkan Inkaya
Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey
4 shared publications
Latest Publications
- 29 September 2026
- Published by Bilimsel Tip Publishing House in İç Hastalıkları Dergisi
- Vol. 27 (2) , 21-30
Prevalence of Cardiovascular–Kidney–Metabolic Syndrome and Its Association with Social Determinants of Health in Hospitalized Internal Medicine Patients
- 29 September 2026
- Published by Bilimsel Tip Publishing House in İç Hastalıkları Dergisi
- Vol. 27 (2) , 21-30
Prevalence of Cardiovascular–Kidney–Metabolic Syndrome and Its Association with Social Determinants of Health in Hospitalized Internal Medicine Patients
- 31 July 2026
- Published by Journal of Exercise Therapy and Rehabilitation in Journal of Exercise Therapy and Rehabilitation
- Vol. 13 (2) , 114-125
Physical activity, psychosocial status, and sleep quality in COVID-19 survivors following telerehabilitation: A prospective intervention and follow-up study
Purpose: Coronavirus disease (COVID-19) has a negative impact on physical activity, anxiety, depression, sleep, and overall quality of life (QoL). Tele-rehabilitation offers an alternative when rehabilitation is not possible. The study was aimed to explore the impact of telerehabilitation on the physical activity, psychosocial status, sleep quality, QoL, and daily activities of living (ADLs) of COVID-19 survivors.Methods: During the pandemic, twenty individuals who were hospitalized due to COVID-19 and subsequently discharged participated in a 12-week telerehabilitation program that included an exercise brochure and telephone calls. The data were collected using Google Forms at discharge and at the 1st, 2nd, 3rd, and 6th months after discharge. The International PA Questionnaire (IPAQ) was used to assess physical activity, while the Hospital Anxiety and Depression Scale (HADS) was used to determine psychosocial status. For sleep quality assessment, the Pittsburgh Sleep Quality Index (PSQI) was used. The Nottingham Health Profile (NHP) was used to assess QoL and the Barthel Index (BI) for ADLs.Results: There was a significant increase in IPAQ total score after telerehabilitation [discharge vs. 3rd month (p=0.006)], with the similarity in IPAQ total score at 3rd vs. 6th months (p>0.007). The HADS anxiety score decreased significantly over its time course compared with the discharge (p
- 31 July 2026
- Published by Journal of Exercise Therapy and Rehabilitation in Journal of Exercise Therapy and Rehabilitation
- Vol. 13 (2) , 114-125
Physical activity, psychosocial status, and sleep quality in COVID-19 survivors following telerehabilitation: A prospective intervention and follow-up study
Purpose: Coronavirus disease (COVID-19) has a negative impact on physical activity, anxiety, depression, sleep, and overall quality of life (QoL). Tele-rehabilitation offers an alternative when rehabilitation is not possible. The study was aimed to explore the impact of telerehabilitation on the physical activity, psychosocial status, sleep quality, QoL, and daily activities of living (ADLs) of COVID-19 survivors.Methods: During the pandemic, twenty individuals who were hospitalized due to COVID-19 and subsequently discharged participated in a 12-week telerehabilitation program that included an exercise brochure and telephone calls. The data were collected using Google Forms at discharge and at the 1st, 2nd, 3rd, and 6th months after discharge. The International PA Questionnaire (IPAQ) was used to assess physical activity, while the Hospital Anxiety and Depression Scale (HADS) was used to determine psychosocial status. For sleep quality assessment, the Pittsburgh Sleep Quality Index (PSQI) was used. The Nottingham Health Profile (NHP) was used to assess QoL and the Barthel Index (BI) for ADLs.Results: There was a significant increase in IPAQ total score after telerehabilitation [discharge vs. 3rd month (p=0.006)], with the similarity in IPAQ total score at 3rd vs. 6th months (p>0.007). The HADS anxiety score decreased significantly over its time course compared with the discharge (p
- 26 March 2026
- Published by Bilimsel Tip Publishing House in İç Hastalıkları Dergisi
- Vol. 27 (1) , 12-20
İç Hastalıklarında Yapay Zeka Uygulamaları: Büyük Dil Modelleri, Makine Öğrenmesi ve Ötesi
- 26 March 2026
- Published by Bilimsel Tip Publishing House in İç Hastalıkları Dergisi
- Vol. 27 (1) , 12-20
İç Hastalıklarında Yapay Zeka Uygulamaları: Büyük Dil Modelleri, Makine Öğrenmesi ve Ötesi
- 2 January 2026
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 138 (1) , 63-70
Association between Hashimoto’s thyroiditis and hemoglobin-albumin-lymphocyte-platelet score and systemic inflammatory index: a nationwide cohort study
Hashimoto's thyroiditis (HT) is a T-cell mediated autoimmune disease characterized by the progressive destruction of thyroid gland. Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score and systemic inflammatory index (SII) are novel markers of inflammation. We aimed to compare HALP score and SII values of patients with HT to those in healthy control subjects in the present study. Patients diagnosed with HT and healthy volunteers (as controls) were included in the study. The SII and HALP score were calculated using the following formulas: SII = (Platelet count×Neutrophil count)/Lymphocyte count. HALP score = (Hemoglobin×Serum Albumin×Lymphocyte count)/Platelet count. SII and HALP score of patients with HT and healthy controls were compared. Median SII of the patients with HT (510 (140-3646)) was significantly higher than that of the control subjects (422 (102-2173)) (p < 0.001). Median HALP score of the HT group (47 (7-149)) was significantly lower than that of the control group (54 (10-160)) (p < 0.001). The sensitivity and specificity of SII (when higher than 452%) in detecting HT were 61% and 62%, respectively (AUC: 0.64, p < 0.001, 95%CI: 0.61-0.67). A HALP score lower than 49.5% threshold had 64% sensitivity and 57% specificity in detecting HT (AUC: 0.61, p < 0.001, 95%CI: 0.57-0.64). In logistic regression analysis (considering age, gender, eGFR, TSH, CRP, ESR, BMI), a unit increase in SII increased the risk of HT by 0.3% (p < 0.001, OR: 1.003, 95%CI: 1.002-1.004). HALP score was also an independent risk factor for HT. A unit increase in HALP score decreased the risk of HT by 2% (p < 0.001, OR: 0.977, 95%CI: 0.968-0.985). We recommend that, due to their inexpensive and easily assessable nature, SII and HALP score could serve as additional diagnostic tools in HT.
- 2 January 2026
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 138 (1) , 63-70
Association between Hashimoto’s thyroiditis and hemoglobin-albumin-lymphocyte-platelet score and systemic inflammatory index: a nationwide cohort study
Hashimoto's thyroiditis (HT) is a T-cell mediated autoimmune disease characterized by the progressive destruction of thyroid gland. Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score and systemic inflammatory index (SII) are novel markers of inflammation. We aimed to compare HALP score and SII values of patients with HT to those in healthy control subjects in the present study. Patients diagnosed with HT and healthy volunteers (as controls) were included in the study. The SII and HALP score were calculated using the following formulas: SII = (Platelet count×Neutrophil count)/Lymphocyte count. HALP score = (Hemoglobin×Serum Albumin×Lymphocyte count)/Platelet count. SII and HALP score of patients with HT and healthy controls were compared. Median SII of the patients with HT (510 (140-3646)) was significantly higher than that of the control subjects (422 (102-2173)) (p < 0.001). Median HALP score of the HT group (47 (7-149)) was significantly lower than that of the control group (54 (10-160)) (p < 0.001). The sensitivity and specificity of SII (when higher than 452%) in detecting HT were 61% and 62%, respectively (AUC: 0.64, p < 0.001, 95%CI: 0.61-0.67). A HALP score lower than 49.5% threshold had 64% sensitivity and 57% specificity in detecting HT (AUC: 0.61, p < 0.001, 95%CI: 0.57-0.64). In logistic regression analysis (considering age, gender, eGFR, TSH, CRP, ESR, BMI), a unit increase in SII increased the risk of HT by 0.3% (p < 0.001, OR: 1.003, 95%CI: 1.002-1.004). HALP score was also an independent risk factor for HT. A unit increase in HALP score decreased the risk of HT by 2% (p < 0.001, OR: 0.977, 95%CI: 0.968-0.985). We recommend that, due to their inexpensive and easily assessable nature, SII and HALP score could serve as additional diagnostic tools in HT.
- 25 March 2025
- Published by Bilimsel Tip Publishing House in İç Hastalıkları Dergisi
- Vol. 1 (1) , 27-28
Nifedipin İlişkili Gingival Hipertrofi Olgusu
- 25 March 2025
- Published by Bilimsel Tip Publishing House in İç Hastalıkları Dergisi
- Vol. 1 (1) , 27-28
Nifedipin İlişkili Gingival Hipertrofi Olgusu
- 25 March 2025
- Published by Bilimsel Tip Publishing House in İç Hastalıkları Dergisi
- Vol. 1 (1) , 16-24
İç Hastalıkları Pratiğinde Primer Kardiyovasküler Koruma için Risk Değerlendirme Yöntemleri
- 25 March 2025
- Published by Bilimsel Tip Publishing House in İç Hastalıkları Dergisi
- Vol. 1 (1) , 16-24
İç Hastalıkları Pratiğinde Primer Kardiyovasküler Koruma için Risk Değerlendirme Yöntemleri
- Open Access
- 23 August 2024
- Published by Karya Journal of Health Science in Karya Journal of Health Science
- Vol. 5 (2) , 51-56
EXERCISE CAPACITY, MUSCLE FUNCTION, FUNCTIONAL BALANCE, AND COGNITIVE STATUS IN PATIENTS WITH POST COVID-19 SYNDROME COMPARED TO HEALTHY CONTROLS
Objective: There is limited data on the effect of post-COVID-19 syndrome on functional outcomes compared with healthy uninfected individuals. This study aimed to compare the muscle function, exercise capacity, and quality of life of patients with post-COVID-19 syndrome with that of healthy controls. Method: Twenty patients with post-COVID-19 syndrome and twenty healthy controls participated in the study. The Incremental Shuttle Walk Test (ISWT) was used to measure exercise capacity, and the Timed Up and Go Test (TUG) was used to assess functional balance. Quadriceps muscle strength (QMS) and handgrip strength (HGS) were measured. Assessment tools included the McGill Pain Questionnaire (SF-MPQ) for pain, the Tampa Scale for Kinesiophobia (TSK) for movement fear, the Modified Medical Research Council Dyspnea Scale (mMRC) for dyspnea, the Fatigue Severity Scale (FSS) for fatigue perception, and the Cognitive Failures Questionnaire (CFQ) for cognitive status. Results: The mMRC dyspnea, TSK, FSS, SF-MPQ total scores, and pain severity of patients with post-COVID-19 syndrome were higher than those of healthy controls (p<.05). Compared to the healthy group, the ISWT and %ISWT distances were significantly lower in the post-COVID-19 group (p<.05). Conclusion: Exercise capacity is negatively affected; anxiety, pain, fatigue severity, dyspnea, and kinesiophobia levels are increased in patients with post-COVID-19 syndrome compared with healthy groups. However, muscle strength, balance, and cognitive function are preserved in individuals with mild-to-moderate COVID-19 infection. Pulmonary rehabilitation programs should be designed on the basis of these multiple influences with a multidisciplinary approach in the long-term rehabilitation of individuals with COVID-19 infection.
- 23 August 2024
- Published by Karya Journal of Health Science in Karya Journal of Health Science
- Vol. 5 (2) , 51-56
Open AccessEXERCISE CAPACITY, MUSCLE FUNCTION, FUNCTIONAL BALANCE, AND COGNITIVE STATUS IN PATIENTS WITH POST COVID-19 SYNDROME COMPARED TO HEALTHY CONTROLS
Objective: There is limited data on the effect of post-COVID-19 syndrome on functional outcomes compared with healthy uninfected individuals. This study aimed to compare the muscle function, exercise capacity, and quality of life of patients with post-COVID-19 syndrome with that of healthy controls. Method: Twenty patients with post-COVID-19 syndrome and twenty healthy controls participated in the study. The Incremental Shuttle Walk Test (ISWT) was used to measure exercise capacity, and the Timed Up and Go Test (TUG) was used to assess functional balance. Quadriceps muscle strength (QMS) and handgrip strength (HGS) were measured. Assessment tools included the McGill Pain Questionnaire (SF-MPQ) for pain, the Tampa Scale for Kinesiophobia (TSK) for movement fear, the Modified Medical Research Council Dyspnea Scale (mMRC) for dyspnea, the Fatigue Severity Scale (FSS) for fatigue perception, and the Cognitive Failures Questionnaire (CFQ) for cognitive status. Results: The mMRC dyspnea, TSK, FSS, SF-MPQ total scores, and pain severity of patients with post-COVID-19 syndrome were higher than those of healthy controls (p<.05). Compared to the healthy group, the ISWT and %ISWT distances were significantly lower in the post-COVID-19 group (p<.05). Conclusion: Exercise capacity is negatively affected; anxiety, pain, fatigue severity, dyspnea, and kinesiophobia levels are increased in patients with post-COVID-19 syndrome compared with healthy groups. However, muscle strength, balance, and cognitive function are preserved in individuals with mild-to-moderate COVID-19 infection. Pulmonary rehabilitation programs should be designed on the basis of these multiple influences with a multidisciplinary approach in the long-term rehabilitation of individuals with COVID-19 infection.
- Open Access
- 1 January 2023
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 45 (özel) , 45-51
Dr. Safiye Ali; Diligent, Determined, Resolute and Compassionate
Türkiye’nin ilk Türk kadın doktoru olan Safiye Ali, 1894 yılında, İstanbul’da doğmuştur. Babası, Sultan Abdülaziz ve II. Abdülhamid'in yaverlerinden Ali Kırat Paşa’dır. Trablusgarp, Balkan ve I. Dünya Savaşları gölgesinde geçen eğitim hayatı şüphesiz doktor olma isteğini etkilemiştir. Amerikan Koleji'nden mezun olduktan sonra, Türkiye’de tıp eğitimi alması mümkün olmadığı için Almanya'ya giden Safiye Ali tüm zorluklara rağmen, okul tatillerini bile gönüllü olarak polikliniklerde çalışarak tıp eğitimini başarıyla bitirmiştir. Uzmanlık eğitimini de Almanya’da kadın ve çocuk hastalıkları alanında yapar. Tıp Fakültesinden arkadaşı Dr. Ferninand Krekeler (Ferdi Ali) ile evlenip İstanbul’a dönen Safiye Ali’nin diploması onaylanır ve Türkiye Cumhuriyeti'nin ilk kadın doktoru olma unvanını alır. Uluslararası kongrelerde Türkiye'yi temsil etmiş, Hilal-i Ahmer ve Himaye-i Etfal Cemiyetlerinde ve Süt Damlası kurumunda çocuk ve kadın sağlığına çok önemli hizmetler vermiştir. Türk Kadınlar Birliği'nde aktif rol almıştır. Ancak bu kurumlarda çıkan anlaşmazlıklar, kendisi ve arkadaşlarının uğradığı haksızlıklar gönül kırıklığı yaratınca istifa ederek Almanya’da dönmüştür. II. Dünya Savaşı boyunca, bombalar altında ve kanserle mücadele ederken doktorluk yapmaya devam etmiştir. Safiye Ali’nin azmi, çalışkanlığı, dik duruşu, kadın- çocuk sağlığına ve koruyucu hekimliğe verdiği önem, yıllar geçtikçe daha iyi anlaşılmaktadır. Bu yazım; bundan tam 100 yıl önce, tüm zorluklara rağmen hayallerinin peşine düşen, hedeflerinden vazgeçmeyen ve ilim için uzak ülkelere tek başına gitmekten çekinmeyen, doğrularından şaşmayan, meslektaşı olmaktan büyük onur duyduğum, maalesef kıymeti yeterince anlaşılamamış çok değerli Safiye Ali’ye bir saygı duruşudur.
- 1 January 2023
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 45 (özel) , 45-51
Open AccessDr. Safiye Ali; Diligent, Determined, Resolute and Compassionate
Türkiye’nin ilk Türk kadın doktoru olan Safiye Ali, 1894 yılında, İstanbul’da doğmuştur. Babası, Sultan Abdülaziz ve II. Abdülhamid'in yaverlerinden Ali Kırat Paşa’dır. Trablusgarp, Balkan ve I. Dünya Savaşları gölgesinde geçen eğitim hayatı şüphesiz doktor olma isteğini etkilemiştir. Amerikan Koleji'nden mezun olduktan sonra, Türkiye’de tıp eğitimi alması mümkün olmadığı için Almanya'ya giden Safiye Ali tüm zorluklara rağmen, okul tatillerini bile gönüllü olarak polikliniklerde çalışarak tıp eğitimini başarıyla bitirmiştir. Uzmanlık eğitimini de Almanya’da kadın ve çocuk hastalıkları alanında yapar. Tıp Fakültesinden arkadaşı Dr. Ferninand Krekeler (Ferdi Ali) ile evlenip İstanbul’a dönen Safiye Ali’nin diploması onaylanır ve Türkiye Cumhuriyeti'nin ilk kadın doktoru olma unvanını alır. Uluslararası kongrelerde Türkiye'yi temsil etmiş, Hilal-i Ahmer ve Himaye-i Etfal Cemiyetlerinde ve Süt Damlası kurumunda çocuk ve kadın sağlığına çok önemli hizmetler vermiştir. Türk Kadınlar Birliği'nde aktif rol almıştır. Ancak bu kurumlarda çıkan anlaşmazlıklar, kendisi ve arkadaşlarının uğradığı haksızlıklar gönül kırıklığı yaratınca istifa ederek Almanya’da dönmüştür. II. Dünya Savaşı boyunca, bombalar altında ve kanserle mücadele ederken doktorluk yapmaya devam etmiştir. Safiye Ali’nin azmi, çalışkanlığı, dik duruşu, kadın- çocuk sağlığına ve koruyucu hekimliğe verdiği önem, yıllar geçtikçe daha iyi anlaşılmaktadır. Bu yazım; bundan tam 100 yıl önce, tüm zorluklara rağmen hayallerinin peşine düşen, hedeflerinden vazgeçmeyen ve ilim için uzak ülkelere tek başına gitmekten çekinmeyen, doğrularından şaşmayan, meslektaşı olmaktan büyük onur duyduğum, maalesef kıymeti yeterince anlaşılamamış çok değerli Safiye Ali’ye bir saygı duruşudur.
- Open Access
- 30 September 2022
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 47 (3) , 1015-1023
The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension
Purpose: In this study, the possible effects of CYP2C9 polymorphisms on the clinical response to losartan were investigated in a group of hypertensive patients. Materials and Methods: Seventy-four patients, newly diagnosed to have essential hypertension, and were subsequently prescribed losartan by attending physicians, were prospectively recruited for the study. Blood pressure measurements at the initiation of losartan treatment and six weeks after were completed for all participants. Genetic analysis for CYP2C9 polymorphisms was performed in blood samples collected at baseline. CYP2C9 *2 and *3 variant alleles were genotyped, and polymorphic patients' treatment responses were compared with the patients' who were carrying the wild type genotype. Results: Analysis comparing the wild type genotype and CYP2C9*1*2 genotype revealed a trend toward more systolic blood pressure reduction in favor of wild-type genotype. However, there was no statistically significant difference between these two groups considering the change in diastolic blood pressure levels. Regarding the CYP2C9*1*3 genotype, there were no significant differences in systolic or diastolic blood pressure changes. Conclusion: CYP2C9*1*2 polymorphism affects the systolic blood pressure response to losartan in hypertensive patients, while the CYP2C9*1*3 genotype was not shown in associated with systolic or diastolic blood pressure responses. Keywords: Hypertension, losartan, CYP2C9, genetic polymorphism, pharmacogenetics
- 30 September 2022
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 47 (3) , 1015-1023
Open AccessThe effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension
Purpose: In this study, the possible effects of CYP2C9 polymorphisms on the clinical response to losartan were investigated in a group of hypertensive patients. Materials and Methods: Seventy-four patients, newly diagnosed to have essential hypertension, and were subsequently prescribed losartan by attending physicians, were prospectively recruited for the study. Blood pressure measurements at the initiation of losartan treatment and six weeks after were completed for all participants. Genetic analysis for CYP2C9 polymorphisms was performed in blood samples collected at baseline. CYP2C9 *2 and *3 variant alleles were genotyped, and polymorphic patients' treatment responses were compared with the patients' who were carrying the wild type genotype. Results: Analysis comparing the wild type genotype and CYP2C9*1*2 genotype revealed a trend toward more systolic blood pressure reduction in favor of wild-type genotype. However, there was no statistically significant difference between these two groups considering the change in diastolic blood pressure levels. Regarding the CYP2C9*1*3 genotype, there were no significant differences in systolic or diastolic blood pressure changes. Conclusion: CYP2C9*1*2 polymorphism affects the systolic blood pressure response to losartan in hypertensive patients, while the CYP2C9*1*3 genotype was not shown in associated with systolic or diastolic blood pressure responses. Keywords: Hypertension, losartan, CYP2C9, genetic polymorphism, pharmacogenetics